See also this year's filing and all EDGAR filings for this company.
PDF Report 0001131324_2016_Genomic_Health_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001131324')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001131324, Genomic Health INC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 1,921,000 |
| 2 | AssetsCurrent | 142,950,000 |
| 3 | PropertyPlantAndEquipment | 39,746,000 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 42,672,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 64,348,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 143,557,000 |
| 15 | ResearchAndDevelopmentExpense | 59,798,000 |
| 16 | remainder_Expenses | 52,786,000 |
| 17 | remainder_Revenues | 287,458,000 |
| 18 | remainder_NetIncome | -277,000 |
| 19 | remainder_ComprehensiveNetIncome | 2,767,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 184,617,000 |
| 1 | Liabilities | 42,672,000 |
| 2 | Expenses | 320,489,000 |
| 3 | Revenues | 287,458,000 |
| 4 | StockholdersEquity | 141,945,000 |
| 5 | NetIncome | -33,308,000 |
| 6 | ComprehensiveNetIncome | -30,541,000 |
| 7 | BaseVar | 419,140,000 |
| 8 | EconomicCapitalRatio | 3.20 |